NDC 76348-590-01 - Hemporrhoid
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 76348-590
- Requested NDC
- 76348-590-01
- Package NDCs from labels
- 76348-590-01, 76348-590-02
- Manufacturer
- Renu Laboratories, Inc.
- Effective date
- 2022-01-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| HEMPORRHOID CREAM | Renu Laboratories, Inc. | 2022-01-14 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 76348-590-02 | 2024-01-30 | C162847 | 48780-1 | 1030e365-05d4-111a-e063-dadaa90a10e2 | HEMPORRHOID CREAM |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76348-590-01 | Hemporrhoid | 28 g in 1 TUBE | CREAM | 28 | 4 | |
| 76348-590-02 | Hemporrhoid | 1 in 1 BOX | CREAM | 1 | 4 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Remodulin | TREPROSTINIL | United Therapeutics Corporation | 6c80bb38-e8db-4138-9f0d-dbbf9c673185 | 2026-07-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Desert Harvest Releveum with Lidocaine | LIDOCAINE HYDROCHLORIDE | Desert Harvest, Inc | 9ad514ab-a6bd-4564-8ba3-0149032ebf36 | 2026-07-01 | Warnings | V13007Z41A |
| Lidovyx | LIDOCAINE 4% | V2 Pharma LLC | 4465eb60-a617-4608-9504-8b3b4c64f49e | 2026-06-30 | Warnings | V13007Z41A |
| FIRST SHIELD | BENZALKONIUM CHLORIDE, LIDOCAINE HCI | Unishield | f86f7446-b741-9f40-e053-6394a90a4422 | 2026-06-29 | Warnings | V13007Z41A |
| GNP Lidocaine Maximum Strength | LIDOCAINE HCL | AMERISOURCE BERGEN | 9f559c20-c9ac-e480-e053-2a95a90a8fce | 2026-06-29 | Warnings | V13007Z41A |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 76176d50-a987-c9f9-e053-2991aa0aea0f | 2026-06-29 | Warnings, Adverse reactions | V13007Z41A |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 552d9018-cc7d-7e1a-e063-6294a90a3322 | 2026-06-26 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 552e16b9-f46a-7838-e063-6394a90ab8aa | 2026-06-26 | Warnings | PDC6A3C0OX |
| Chemstat | GLYCERINUM, TARAXACUM OFFICINALE, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, BOVISTA, CARBO VEGETABILIS, CARBONEUM SULPHURATUM, COFFEA CRUDA, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, SULPHUR, ACETYLSALICYLICUM ACIDUM, FORMALINUM, GLONOINUM, INSULINUM (HUMAN), LITHIUM CARBONICUM, TEREBINTHINA, THYROIDINUM (SUIS), ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, | Energique, Inc. | 2e361b50-9268-4053-b13c-93af64549848 | 2026-06-25 | Warnings | PDC6A3C0OX |
| Nervionoix Pro Neuropathy Fast Acting Cream | LIDOCAINE HYDROCHLORIDE, MENTHOL,MAGNESIUM CHLORIDE | Micelle Laboratories, Incorporated | 23abdf62-03a8-4aaa-8e29-0e2585b5ade7 | 2026-06-24 | Warnings | V13007Z41A |
| Fendall 2000 Pure Flow | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 37dead3e-60cb-88ae-e063-6294a90a8f70 | 2026-06-24 | Warnings | 059QF0KO0R |
| Bacteriostatic Water | BACTERIOSTATIC WATER | Fujian Genohope Biotech Ltd. | 54f66b82-c9e5-a2bc-e063-6394a90adbbc | 2026-06-23 | 059QF0KO0R | |
| LIDOCAINE HCl AND EPINEPHRINE | LIDOCAINE HCL AND EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | a09613b2-4337-5b52-e053-2995a90ab74b | 2026-06-19 | Warnings, Adverse reactions | V13007Z41A |
| Pain Relieving cleansing spary | BENZALKONIUM CHLORIDE AND LIDOCAINE HCI | Trifecta Pharmaceuticals USA, LLC. | 48edbb8d-0c35-91d8-e063-6394a90a71b8 | 2026-06-19 | Warnings | V13007Z41A |
| Humalog | INSULIN LISPRO | Eli Lilly and Company | c8ecbd7a-0e22-4fc7-a503-faa58c1b6f3f | 2026-06-16 | Warnings, Adverse reactions | 059QF0KO0R |
| Glycerin | GLYCERIN SUPPOSITORY | Everpharm LLC | 546347e5-841e-15ca-e063-6294a90a0c8b | 2026-06-16 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN SUPPOSITORY | Everpharm LLC | 5463f869-2b92-4551-e063-6394a90ad6f9 | 2026-06-16 | Warnings | PDC6A3C0OX |
| MINICA-S | GLYCERIN | Sato Pharmaceutical Co., Ltd. | 687902eb-e702-4e87-a0ce-9add05e3cbc1 | 2026-06-16 | Warnings | PDC6A3C0OX |
| Lidozall Pro | LIDOCAINE HYDROCHLORIDE | V2 Pharma LLC | ecc26ba7-4ff6-43e6-bfb9-91a9cbb509ff | 2026-06-16 | Warnings | V13007Z41A |
| WALGREEN GLYCERIN ADULT | GLYCERIN SUPPOSITORY | Walgreens | 20c44346-0b29-7364-e063-6294a90a648f | 2026-06-15 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.